Strategic Investment Advisors’s Boston Scientific BSX Stock Holding History

Strategic Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$471K	Sell	11,033 -2,775	-20%	-$151K	0.03%	221
2026 Q1	$812K	Buy	+13,808	New	+$1.1M	0.06%	166
2025 Q3	–	Sell	-8,860	Closed	-$945K	–	268
2025 Q2	$945K	Sell	8,860 -2,676	-23%	-$271K	0.09%	104
2025 Q1	$1.16M	Sell	11,536 -806	-7%	-$81.2K	0.12%	92
2024 Q4	$1.1M	Sell	12,342 -1,011	-8%	-$89K	0.12%	102
2024 Q3	$1.12M	Sell	13,353 -548	-4%	-$43.2K	0.12%	106
2024 Q2	$1.07M	Buy	13,901 +1,705	+14%	+$125K	0.13%	100
2024 Q1	$835K	Sell	12,196 -812	-6%	-$52.2K	0.11%	122
2023 Q4	$752K	Sell	13,008 -811	-6%	-$43.3K	0.11%	125
2023 Q3	$730K	Buy	13,819 +4,170	+43%	+$219K	0.12%	126
2023 Q2	$522K	Sell	9,649 -266	-3%	-$13.9K	0.07%	135
2023 Q1	$496K	Buy	+9,915	New	+$467K	0.09%	161

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Strategic Investment Advisors's BSX Position: Q2 2026 in Review

Strategic Investment Advisors reduced its Boston Scientific (BSX) stake by 20% in Q2 2026, selling an estimated $151K and leaving 11,033 shares worth $471K. The position accounts for 0.03% of the portfolio, ranked #221.

Strategic Investment Advisors first reported a position in BSX in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.16M in Q1 2025. 1,485 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Strategic Investment Advisors held 11,033 shares of Boston Scientific worth $471K as of Q2 2026.
Strategic Investment Advisors sold 2,775 Boston Scientific shares in Q2 2026, an estimated $151K.
Boston Scientific made up 0.03% of Strategic Investment Advisors's portfolio in Q2 2026, its #221 holding.
Strategic Investment Advisors first reported a position in Boston Scientific in Q1 2023 and has held it in 12 quarters since.
Strategic Investment Advisors's Boston Scientific position peaked at $1.16M in Q1 2025.
1,485 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Strategic Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.